Change Alone is Unchanging
http://www.100md.com
《临床内分泌与代谢杂志》
This month’s issue of The Journal of Clinical Endocrinology and Metabolism introduces several changes that the new editors hope will make the journal even more interesting and useful to our readers. The addition of a cover image is the most obvious enhancement, but alert readers will find a number of other modifications in JCEM’s format and editorial policies. The table of contents typography and order of manuscripts have both changed. Original articles now come first, followed by special features, editorials and letters to the editor—a more conventional format for biomedical journals. Some original articles are still categorized as "Endocrine Care," but the blue typeface for these listings is gone. This designation for some papers is intended by The Endocrine Society to be an affirmation of JCEM’s clinical relevance to our readers.
A new "Listing by Interests," which follows the table of contents on a conveniently tabbed page, enables readers to focus on content of greatest relevance to their particular field. Another new feature, "Endocrinology and Metabolism News," is a compilation of the latest developments in endocrine research, practice, policy, and training, as well as news about our colleagues in endocrinology. The "News" advances the vision of my highly successful predecessor, John Bilezikian, that "JCEM will be the journal that every clinical endocrinologist must read every month; and if they do, it will be the only journal that they must read." The editors welcome the submission of news items from the readership.
Behind the scenes, there are other significant changes in the Journal’s editorial policies and procedures. Three reviewers, rather than two, will now be sought for original articles, with the intent of providing even more thoughtful and balanced feedback to authors. Consequently, the editorial board has been expanded by almost 30% to strengthen the journal’s cadre of committed reviewers. Those planning to submit papers are urged to read carefully the revised Instructions for Authors, which redefine our article categories and articulate new structured abstract requirements and new limitations on the length of articles. These word, table, figure, and reference limitations are intended to address a happy challenge faced by JCEM: the steady increase in worthy submissions for limited page space. These new standards should make our content richer and clearer, rather than the alternative solutions of rejecting deserving submissions or allowing the journal to get even thicker, subjecting our readers to lumbago.
JCEM has become increasingly electronically enabled. Virtually all manuscripts are now submitted online and, effective April 1, 2005, all papers will have to be submitted in this manner. Beginning with the articles in this issue, accepted papers have been previously posted online as Rapid Electronic Publications (http://jcem.endojournals.org/rep.shtml) within days of their acceptance. These articles were also promptly listed and citable through Medline. Reflecting The Endocrine Society’s commitment to provide public access to the very latest medical literature, these rapid electronic publications are freely retrievable online from the time of acceptance until their print publication several months later. Simultaneous with print publication, JCEM’s contents are available to subscribers online (http://jcem.endojournals.org/) in downloadable PDF and HTML versions, with figures that can be captured for presentations, and linkage to cited references through Medline.
Beneath these refinements, the Journal of Clinical Endocrinology and Metabolism is committed to certain values that have not and will not change. JCEM is the premier publication in endocrinology, diabetes, and metabolism for authors reporting novel and important advances in related clinical science. These authors are our most important constituency. We are very grateful to them, and we promise them thoughtful, balanced, respectful, and timely peer review. We intend to render an initial decision about submitted papers within one month. JCEM is also committed to our readers: the subspecialty clinicians and clinical investigators who expect the journal to help them keep pace with the latest developments in our field. To all of you, JCEM’s editors and editorial board pledge to deliver to your doorstep and computer an informative, useful, and stimulating issue every month. Let us know how you think we are doing.
Footnotes
1 Heraclitus (c. 535–c. 475 B.C.).(Paul W. Ladenson, M.D.)
A new "Listing by Interests," which follows the table of contents on a conveniently tabbed page, enables readers to focus on content of greatest relevance to their particular field. Another new feature, "Endocrinology and Metabolism News," is a compilation of the latest developments in endocrine research, practice, policy, and training, as well as news about our colleagues in endocrinology. The "News" advances the vision of my highly successful predecessor, John Bilezikian, that "JCEM will be the journal that every clinical endocrinologist must read every month; and if they do, it will be the only journal that they must read." The editors welcome the submission of news items from the readership.
Behind the scenes, there are other significant changes in the Journal’s editorial policies and procedures. Three reviewers, rather than two, will now be sought for original articles, with the intent of providing even more thoughtful and balanced feedback to authors. Consequently, the editorial board has been expanded by almost 30% to strengthen the journal’s cadre of committed reviewers. Those planning to submit papers are urged to read carefully the revised Instructions for Authors, which redefine our article categories and articulate new structured abstract requirements and new limitations on the length of articles. These word, table, figure, and reference limitations are intended to address a happy challenge faced by JCEM: the steady increase in worthy submissions for limited page space. These new standards should make our content richer and clearer, rather than the alternative solutions of rejecting deserving submissions or allowing the journal to get even thicker, subjecting our readers to lumbago.
JCEM has become increasingly electronically enabled. Virtually all manuscripts are now submitted online and, effective April 1, 2005, all papers will have to be submitted in this manner. Beginning with the articles in this issue, accepted papers have been previously posted online as Rapid Electronic Publications (http://jcem.endojournals.org/rep.shtml) within days of their acceptance. These articles were also promptly listed and citable through Medline. Reflecting The Endocrine Society’s commitment to provide public access to the very latest medical literature, these rapid electronic publications are freely retrievable online from the time of acceptance until their print publication several months later. Simultaneous with print publication, JCEM’s contents are available to subscribers online (http://jcem.endojournals.org/) in downloadable PDF and HTML versions, with figures that can be captured for presentations, and linkage to cited references through Medline.
Beneath these refinements, the Journal of Clinical Endocrinology and Metabolism is committed to certain values that have not and will not change. JCEM is the premier publication in endocrinology, diabetes, and metabolism for authors reporting novel and important advances in related clinical science. These authors are our most important constituency. We are very grateful to them, and we promise them thoughtful, balanced, respectful, and timely peer review. We intend to render an initial decision about submitted papers within one month. JCEM is also committed to our readers: the subspecialty clinicians and clinical investigators who expect the journal to help them keep pace with the latest developments in our field. To all of you, JCEM’s editors and editorial board pledge to deliver to your doorstep and computer an informative, useful, and stimulating issue every month. Let us know how you think we are doing.
Footnotes
1 Heraclitus (c. 535–c. 475 B.C.).(Paul W. Ladenson, M.D.)